Is Isovaleric acidemia hereditary?

Isovaleric acidemia is an inherited metabolic disorder caused by mutations in the IVD gene, which is passed from parents to children through an autosomal recessive inheritance pattern. Because it is a genetic condition, both biological parents must typically be carriers of the mutation for a child to be affected, resulting in a 25% risk of recurrence for each pregnancy in carrier couples.

Is Isovaleric acidemia a hereditary condition?

Yes, isovaleric acidemia is a strictly hereditary condition, meaning it is caused by genetic changes that are passed down through families. It is not caused by external environmental factors or lifestyle choices. In medical terms, we classify isovaleric acidemia as an autosomal recessive disorder. This means that an individual must inherit two copies of the mutated IVD gene—one from each parent—to manifest the symptoms of the disease. Parents who each carry one mutated gene and one normal gene are known as "carriers." Carriers do not typically show symptoms of isovaleric acidemia because their functional gene produces enough enzyme activity to maintain normal metabolic processes.

What are the inheritance risks for future children?

When both parents are confirmed carriers of an IVD gene mutation, the biological probability for each pregnancy follows a predictable pattern:

• 25% chance the child will inherit two mutated genes and develop isovaleric acidemia.


• 50% chance the child will inherit one mutated gene and one normal gene, becoming an asymptomatic carrier like the parents.


• 25% chance the child will inherit two normal genes and be neither affected nor a carrier.

De novo (spontaneous) mutations that occur for the first time in a child without either parent being a carrier are extremely rare in isovaleric acidemia. The vast majority of cases are inherited from parents who were previously unaware of their carrier status.

How is genetic testing and counseling utilized?

Genetic testing is the gold standard for confirming a diagnosis of isovaleric acidemia. This is typically performed via molecular genetic testing of the IVD gene, often following a positive newborn screening result that shows elevated isovalerylcarnitine levels. Genetic counseling is highly recommended for all families affected by isovaleric acidemia. A counselor can help explain the inheritance risks, interpret complex lab results, and provide guidance on reproductive options. For families planning future pregnancies, options such as prenatal diagnosis (via amniocentesis or chorionic villus sampling) or preimplantation genetic testing (PGT) during IVF may be available to identify whether an embryo carries the familial mutations.

Next steps

• Consult with a clinical geneticist or a metabolic specialist to confirm IVD gene mutation status.


• Connect with the 23 members of the isovaleric acidemia community at DiseaseMaps.org to share experiences and find support.


• Request a referral to a genetic counselor to map out family inheritance patterns and discuss family planning.


• Ensure that all first-degree relatives of an affected individual are offered carrier testing.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Isovaleric acidemia.


• Orphanet: Isovaleric acidemia (ORPHA:44).


• OMIM (Online Mendelian Inheritance in Man): Isovaleryl-CoA dehydrogenase deficiency (#243500).


• Organic Acidemia Association: Educational resources for metabolic disorders.